Patent details

EP3811941 Title: PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE AND SALT THEREOF AND PREPARATION METHOD THEREFOR

Basic Information

Publication number:
EP3811941
PCT Application Number:
CN2018111611
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP189236797
PCT Publication Number:
WO2019242181
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE AND SALT THEREOF AND PREPARATION METHOD THEREFOR
French Title of Invention:
COMPOSITION PHARMACEUTIQUE CONTENANT DE L'ILAPRAZOLE ET UN SEL DE CELUI-CI ET SON PROCÉDÉ DE PRÉPARATION
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT ILAPRAZOL UND SALZ DAVON UND VERFAHREN ZU IHRER HERSTELLUNG
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
21/12/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
08/01/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
29/11/2023
Unitary Effect Registration Date:
08/01/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
24/10/2018
Grant date:
29/11/2023
EP Publication Date:
28/04/2021
PCT Publication Date:
26/12/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/11/2023
EP B1 Publication Date:
29/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/10/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/11/2023
 
 

Name:
Livzon Pharmaceutical Group Co., Ltd
Address:
38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong 519090, China (CN)

Inventor

1

Name:
CHEN, Jialu
Address:
China (CN)

2

Name:
LU, Wenqi
Address:
China (CN)

3

Name:
LI, Jing
Address:
China (CN)

4

Name:
WANG, Tao
Address:
China (CN)

5

Name:
ZHANG, Xiangna
Address:
China (CN)

6

Name:
HOU, Xuemei
Address:
China (CN)

7

Name:
ZHANG, Yurong
Address:
China (CN)

8

Name:
CHEN, Hongdan
Address:
China (CN)

9

Name:
KONG, Xiangsheng
Address:
China (CN)

10

Name:
TU, Zengqing
Address:
China (CN)

11

Name:
WU, Xiaohong
Address:
China (CN)

12

Name:
CHENG, Caihua
Address:
China (CN)

Priority

Priority Number:
201810652046
Priority Date:
22/06/2018
Priority Country:
China (CN)

Classification

IPC classification:
A61K 31/4439; A61K 9/19; A61K 47/02; A61P 1/04; A61K 9/00; A61K 47/26; A61K 47/18;

Publication

European Patent Bulletin

1

Issue number:
202348
Publication date:
29/11/2023
Description:
Grant (B1)

2

Issue number:
202404
Publication date:
24/01/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202406
Publication date:
07/02/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages